Literature DB >> 19956023

Conservative management of pancreatic pseudocysts in children with acute lymphoblastic leukemia.

Holly L Spraker1, Georgios P Spyridis, Ching-Hon Pui, Scott C Howard.   

Abstract

Treatment with asparaginase for acute lymphoblastic leukemia can cause acute pancreatitis. Complication of pancreatitis by pancreatic pseudocyst formation can prolong the hospital stay, delay chemotherapy, and necessitate long-term parenteral nutrition. We report 5 children with acute lymphoblastic leukemia who developed acute pancreatitis complicated by pancreatic pseudocysts. They required modifications to their chemotherapy regimen and prolonged parenteral nutrition but no surgical intervention. All 5 patients survive in first remission and their pseudocysts resolved after 3 to 37 months or continued to decrease in size at last follow-up. These cases illustrate that nonsurgical management of pancreatic pseudocyst is safe, though pseudocyst resolution may require many months. In addition, these patients demonstrate that oral feeding can be initiated after the acute episode of pancreatitis resolves even if a pseudocyst is present.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19956023      PMCID: PMC2811578          DOI: 10.1097/MPH.0b013e3181ba9e6a

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  13 in total

Review 1.  Pancreatic pseudocysts in the 21st century. Part II: natural history.

Authors:  Ake Andrén-Sandberg; Christos Dervenis
Journal:  JOP       Date:  2004-03

Review 2.  Treatment of acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; William E Evans
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

Review 3.  Acute pancreatitis.

Authors:  W Steinberg; S Tenner
Journal:  N Engl J Med       Date:  1994-04-28       Impact factor: 91.245

4.  Pseudocysts in acute nonalcoholic pancreatitis: incidence and natural history.

Authors:  A Maringhini; G Uomo; R Patti; P Rabitti; A Termini; A Cavallera; G Dardanoni; G Manes; M Ciambra; M Laccetti; P Biffarella; L Pagliaro
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

Review 5.  Issues in management of pancreatic pseudocysts.

Authors:  Dinesh Singhal; Rahul Kakodkar; Randhir Sud; Adarsh Chaudhary
Journal:  JOP       Date:  2006-09-10

6.  Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.

Authors:  M D Amylon; J Shuster; J Pullen; C Berard; M P Link; M Wharam; J Katz; A Yu; J Laver; Y Ravindranath; J Kurtzberg; S Desai; B Camitta; S B Murphy
Journal:  Leukemia       Date:  1999-03       Impact factor: 11.528

7.  Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

Authors:  L B Silverman; R D Gelber; V K Dalton; B L Asselin; R D Barr; L A Clavell; C A Hurwitz; A Moghrabi; Y Samson; M A Schorin; S Arkin; L Declerck; H J Cohen; S E Sallan
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

8.  Conservative treatment as an option in the management of pancreatic pseudocyst.

Authors:  C V N Cheruvu; M G Clarke; M Prentice; I A Eyre-Brook
Journal:  Ann R Coll Surg Engl       Date:  2003-09       Impact factor: 1.891

9.  Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.

Authors:  Ching-Hon Pui; John T Sandlund; Deqing Pei; Dario Campana; Gaston K Rivera; Raul C Ribeiro; Jeffrey E Rubnitz; Bassem I Razzouk; Scott C Howard; Melissa M Hudson; Cheng Cheng; Larry E Kun; Susana C Raimondi; Frederick G Behm; James R Downing; Mary V Relling; William E Evans
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

10.  Selected management of pancreatic pseudocysts: operative versus expectant management.

Authors:  G J Vitas; M G Sarr
Journal:  Surgery       Date:  1992-02       Impact factor: 3.982

View more
  6 in total

1.  Crizotinib-induced pancreatic pseudocyst: a novel adverse event.

Authors:  Hiroo Ishida; Wataru Ichikawa; Yasutsuna Sasaki
Journal:  BMJ Case Rep       Date:  2015-09-08

2.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

3.  L-asparginase induced pseudopancreatic cyst: a rare case report.

Authors:  S M Abhayakumar; Samit Purohit; B S Arunakumari; K C Lakshmaiah; L Appaji
Journal:  Indian J Surg Oncol       Date:  2013-08-18

4.  Association of asparaginase-associated pancreatitis and ULK2 gene polymorphism.

Authors:  Juxiang Wang; Shengqin Cheng; Linglong Hu; Tingting Huang; Zhen Huang; Shaoyan Hu
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

Review 5.  Acute pancreatitis as a complication of childhood cancer treatment.

Authors:  Milica Stefanović; Janez Jazbec; Fredrik Lindgren; Milutin Bulajić; Matthias Löhr
Journal:  Cancer Med       Date:  2016-02-13       Impact factor: 4.452

Review 6.  Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.

Authors:  Kjeld Schmiegelow; Klaus Müller; Signe Sloth Mogensen; Pernille Rudebeck Mogensen; Benjamin Ole Wolthers; Ulrik Kristoffer Stoltze; Ruta Tuckuviene; Thomas Frandsen
Journal:  F1000Res       Date:  2017-04-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.